Cargando…

Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan

BACKGROUND: Addressing the global burden of multidrug-resistant tuberculosis (MDR-TB) requires identification of shorter, less toxic treatment regimens. Médecins Sans Frontières (MSF) is currently conducting a phase II/III randomised controlled clinical trial, to find more effective, shorter and tol...

Descripción completa

Detalles Bibliográficos
Autores principales: Wharton-Smith, Alexandra, Horter, Shona, Douch, Emma, Gray, Nell, James, Nicola, Nyang’wa, Bern-Thomas, Singh, Jatinder, Nusratovna, Parpieva Nargiza, Tigay, Zinaida, Kazounis, Emil, Allanazarova, Gulayim, Stringer, Beverley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645116/
https://www.ncbi.nlm.nih.gov/pubmed/34863253
http://dx.doi.org/10.1186/s13063-021-05850-0
_version_ 1784610242641788928
author Wharton-Smith, Alexandra
Horter, Shona
Douch, Emma
Gray, Nell
James, Nicola
Nyang’wa, Bern-Thomas
Singh, Jatinder
Nusratovna, Parpieva Nargiza
Tigay, Zinaida
Kazounis, Emil
Allanazarova, Gulayim
Stringer, Beverley
author_facet Wharton-Smith, Alexandra
Horter, Shona
Douch, Emma
Gray, Nell
James, Nicola
Nyang’wa, Bern-Thomas
Singh, Jatinder
Nusratovna, Parpieva Nargiza
Tigay, Zinaida
Kazounis, Emil
Allanazarova, Gulayim
Stringer, Beverley
author_sort Wharton-Smith, Alexandra
collection PubMed
description BACKGROUND: Addressing the global burden of multidrug-resistant tuberculosis (MDR-TB) requires identification of shorter, less toxic treatment regimens. Médecins Sans Frontières (MSF) is currently conducting a phase II/III randomised controlled clinical trial, to find more effective, shorter and tolerable treatments for people with MDR-TB. Recruitment to the trial in Uzbekistan has been slower than expected; we aimed to study patient and health worker experiences of the trial, examining potential factors perceived to impede and facilitate trial recruitment, as well as general perceptions of clinical research in this context. METHODS: We conducted a qualitative study using maximum variation, purposive sampling of participants. We carried out in-depth interviews (IDIs) and focus group discussions (FGDs) guided by semi-structured topic guides. In December 2019 and January 2020, 26 interviews were conducted with patients, Ministry of Health (MoH) and MSF staff and trial health workers, to explore challenges and barriers to patient recruitment as well as perceptions of the trial and research in general. Preliminary findings from the interviews informed three subsequent focus group discussions held with patients, nurses and counsellors. Focus groups adopted a person-centred design, brainstorming potential solutions to problems and barriers. Interviews and FGDs were audio recorded, translated and transcribed verbatim. Thematic analysis, drawing on constant comparison, was used to analyse the data. RESULTS: Health system contexts may compete with new approaches especially when legislative health regulations or policy around treatment is ingrained in staff beliefs, perceptions and practice, which can undermine clinical trial recruitment. Trust plays a significant role in how patients engage with the trial. Decision-making processes are dynamic and associated with relationship to diagnosis, assimilation of information, previous knowledge or experience and influence of peers and close relations. CONCLUSIONS: This qualitative analysis highlights ways in which insights developed together with patients and healthcare workers might inform approaches towards improved recruitment into trials, with the overall objective of delivering evidence for better treatments.
format Online
Article
Text
id pubmed-8645116
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86451162021-12-06 Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan Wharton-Smith, Alexandra Horter, Shona Douch, Emma Gray, Nell James, Nicola Nyang’wa, Bern-Thomas Singh, Jatinder Nusratovna, Parpieva Nargiza Tigay, Zinaida Kazounis, Emil Allanazarova, Gulayim Stringer, Beverley Trials Research BACKGROUND: Addressing the global burden of multidrug-resistant tuberculosis (MDR-TB) requires identification of shorter, less toxic treatment regimens. Médecins Sans Frontières (MSF) is currently conducting a phase II/III randomised controlled clinical trial, to find more effective, shorter and tolerable treatments for people with MDR-TB. Recruitment to the trial in Uzbekistan has been slower than expected; we aimed to study patient and health worker experiences of the trial, examining potential factors perceived to impede and facilitate trial recruitment, as well as general perceptions of clinical research in this context. METHODS: We conducted a qualitative study using maximum variation, purposive sampling of participants. We carried out in-depth interviews (IDIs) and focus group discussions (FGDs) guided by semi-structured topic guides. In December 2019 and January 2020, 26 interviews were conducted with patients, Ministry of Health (MoH) and MSF staff and trial health workers, to explore challenges and barriers to patient recruitment as well as perceptions of the trial and research in general. Preliminary findings from the interviews informed three subsequent focus group discussions held with patients, nurses and counsellors. Focus groups adopted a person-centred design, brainstorming potential solutions to problems and barriers. Interviews and FGDs were audio recorded, translated and transcribed verbatim. Thematic analysis, drawing on constant comparison, was used to analyse the data. RESULTS: Health system contexts may compete with new approaches especially when legislative health regulations or policy around treatment is ingrained in staff beliefs, perceptions and practice, which can undermine clinical trial recruitment. Trust plays a significant role in how patients engage with the trial. Decision-making processes are dynamic and associated with relationship to diagnosis, assimilation of information, previous knowledge or experience and influence of peers and close relations. CONCLUSIONS: This qualitative analysis highlights ways in which insights developed together with patients and healthcare workers might inform approaches towards improved recruitment into trials, with the overall objective of delivering evidence for better treatments. BioMed Central 2021-12-04 /pmc/articles/PMC8645116/ /pubmed/34863253 http://dx.doi.org/10.1186/s13063-021-05850-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wharton-Smith, Alexandra
Horter, Shona
Douch, Emma
Gray, Nell
James, Nicola
Nyang’wa, Bern-Thomas
Singh, Jatinder
Nusratovna, Parpieva Nargiza
Tigay, Zinaida
Kazounis, Emil
Allanazarova, Gulayim
Stringer, Beverley
Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan
title Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan
title_full Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan
title_fullStr Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan
title_full_unstemmed Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan
title_short Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan
title_sort optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in uzbekistan
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645116/
https://www.ncbi.nlm.nih.gov/pubmed/34863253
http://dx.doi.org/10.1186/s13063-021-05850-0
work_keys_str_mv AT whartonsmithalexandra optimisingrecruitmenttoalatephasetuberculosisclinicaltrialaqualitativestudyexploringpatientandpractitionerexperiencesinuzbekistan
AT hortershona optimisingrecruitmenttoalatephasetuberculosisclinicaltrialaqualitativestudyexploringpatientandpractitionerexperiencesinuzbekistan
AT douchemma optimisingrecruitmenttoalatephasetuberculosisclinicaltrialaqualitativestudyexploringpatientandpractitionerexperiencesinuzbekistan
AT graynell optimisingrecruitmenttoalatephasetuberculosisclinicaltrialaqualitativestudyexploringpatientandpractitionerexperiencesinuzbekistan
AT jamesnicola optimisingrecruitmenttoalatephasetuberculosisclinicaltrialaqualitativestudyexploringpatientandpractitionerexperiencesinuzbekistan
AT nyangwabernthomas optimisingrecruitmenttoalatephasetuberculosisclinicaltrialaqualitativestudyexploringpatientandpractitionerexperiencesinuzbekistan
AT singhjatinder optimisingrecruitmenttoalatephasetuberculosisclinicaltrialaqualitativestudyexploringpatientandpractitionerexperiencesinuzbekistan
AT nusratovnaparpievanargiza optimisingrecruitmenttoalatephasetuberculosisclinicaltrialaqualitativestudyexploringpatientandpractitionerexperiencesinuzbekistan
AT tigayzinaida optimisingrecruitmenttoalatephasetuberculosisclinicaltrialaqualitativestudyexploringpatientandpractitionerexperiencesinuzbekistan
AT kazounisemil optimisingrecruitmenttoalatephasetuberculosisclinicaltrialaqualitativestudyexploringpatientandpractitionerexperiencesinuzbekistan
AT allanazarovagulayim optimisingrecruitmenttoalatephasetuberculosisclinicaltrialaqualitativestudyexploringpatientandpractitionerexperiencesinuzbekistan
AT stringerbeverley optimisingrecruitmenttoalatephasetuberculosisclinicaltrialaqualitativestudyexploringpatientandpractitionerexperiencesinuzbekistan